Drug intelligence / Profile preview

AMPCPR

Development stage
Unknown
Modality
Small Molecules
01

Overview

AMPCPR is a synthetic purine ribonucleoside monophosphate analog with the chemical formula C16H25N5O13P2 and a molecular weight of approximately 557.34 g/mol. It is also known as alpha-beta methylene ADP-ribose. This compound is classified as an experimental small molecule and has not been approved for any clinical use or indication. Its structure mimics that of adenosine diphosphate ribose (ADP-ribose), suggesting potential utility in biochemical research related to nucleotide metabolism or enzyme inhibition studies; however, no specific mechanism of action or therapeutic application has been established in humans[1][2].

Other names
alpha-beta methylene ADP-ribose(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)(hydroxy)phosphoryl)methyl)((((2R,3S,4R,5S)-3,4,5-trihydroxyoxolan-2-yl)methoxy))phosphinic acid

Beyond the preview

Go deeper on AMPCPR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMPCPR.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call